HER2 Activation and Endocrine Treatment Resistance in HER2-negative Breast Cancer is a research paper published in Endocrinology (2021). On theSindex it has a DataRank of 0. It has been cited 31 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Department of Defense Breakthrough
Grant: W81XWH-18-1-0034
Susan G. Komen Career Catalyst
Grant: CCR18548157
National Cancer Institute
Grant: P30CA030199
National Cancer Institute
Grant: CA229613
NCI NIH HHS
Grant: K22 CA229613
National Institutes of Health
FWCI
1.70
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals